The Wegovy shortage is causing thousands to turn to copies. What will the FDA do about it?

Patients who cannot afford Wegovy or have struggled to find it have been turning to often-cheaper compounded versions sold by pharmacies.

More than 200,000 prescriptions for copies of Novo Nordisk’s weight-loss drug Wegovy are getting filled by U.S. patients each month, an industry group told the U.S. drugs regulator in a letter, saying it should consider their role in alleviating the obesity drug supply crunch before barring them.